precisely remodelling tissues.

profoundly reshaping lives.

We convert the power of selective fibroblast modulation into transformative therapeutics. Pathologically activated fibroblasts orchestrate abnormal tissue structure and drive many diseases. Our technology modulates of disease-associated fibroblasts with unprecedented selectivity, resulting in precise tissue remodeling and normalization, and generating multiple therapeutic benefits.

Our mission is to profoundly reshape the lives of people affected by cancer and fibrotic diseases.

latest news.

10/10/2023: Amalus Therapeutics nominated for One-to-Watch Award of OBN!

We use cookies to ensure the proper functioning and security of our website and to provide you with the best possible user experience.

Advanced settings

You can adjust your cookie preferences here. Enable or disable the following categories and save the selection. 

The essential cookies are essential for the safe and correct operation of our website and the registration process. 
Functional cookies remember your preferences for our website and make it possible to adjust them.
Performance cookies monitor the performance of our website.
Marketing cookies enable us to measure and analyze the performance of our website.